NIZZARDO, MONICA
NIZZARDO, MONICA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Targeting PTB for Glia‐to‐Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases
2022 M. Contardo, R. De Gioia, D. Gagliardi, G.P. Comi, L. Ottoboni, M. Nizzardo, S. Corti
Generation of two hiPSC lines (UMILi027-A and UMILi028-A) from early and late-onset Congenital Central hypoventilation Syndrome (CCHS) patients carrying a polyalanine expansion mutation in the PHOX2B gene
2022 A.L. Cuadros Gamboa, R. Benfante, M. Nizzardo, T. Bachetti, P. Pelucchi, V. Melzi, C. Arzilli, M. Peruzzi, R.A. Reinbold, S. Cardani, A. Morrone, R. Guerrini, I. Zucchi, S. Corti, I. Ceccherini, R. Piumelli, N. Nassi, S. Di Lascio, D. Fornasari
Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
2022 D. Gagliardi, E. Pagliari, M. Meneri, V. Melzi, F. Rizzo, G.P. Comi, S.P. Corti, M.M. Taiana, M. Nizzardo
Molecular analysis of SMARD1 patient-derived cells demonstrates that nonsense-mediated mRNA decay is impaired
2022 M. Taiana, A. Govoni, S. Salani, N. Kleinschmidt, N. Galli, M. Saladini, S.B. Ghezzi, V. Melzi, M. Bersani, R. Del Bo, O. Muehlemann, E. Bertini, V. Sansone, E. Albamonte, S. Messina, F. Mari, E. Cesaroni, L. Porfiri, F.D. Tiziano, G.L. Vita, M. Sframeli, C. Bonanno, N. Bresolin, G. Comi, S. Corti, M. Nizzardo
Morpholino oligomers ameliorates pathological hallmarks in C9orf72 cellular lines and mice
2021 M. Bersani, D. Gagliardi, M. Taiana, F. Biella, M. Nizzardo, S. Corti
Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
2021 M. Bersani, M. Rizzuti, E. Pagliari, M. Garbellini, D. Saccomanno, H.M. Moulton, N. Bresolin, G.P. Comi, S. Corti, M. Nizzardo
Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients
2021 C. Malacarne, M. Galbiati, E. Giagnorio, P. Cavalcante, F. Salerno, F. Andreetta, C. Cagnoli, M. Taiana, M. Nizzardo, S. Corti, V. Pensato, A. Venerando, C. Gellera, S. Fenu, D. Pareyson, R. Masson, L. Maggi, E. Dalla Bella, G. Lauria, R. Mantegazza, P. Bernasconi, A. Poletti, S. Bonanno, S. Marcuzzo
CPPs-conjugated antisense nucleotides : a new therapeutic strategy for Spinal Muscular Atrophy symptomatic patients
2020 E. Pagliari, M. Bersani, M. Rizzuti, A. Bordoni, D. Saccomanno, N. Bresolin, G. Comi, S. Corti, M. Nizzardo
Optimization of AAV9 gene therapy for Spinal Muscular Atrophy with respiratory distress Type 1 using in vivo disease models
2020 E. Pagliari, P. Rinchetti, N. Galli, S. Ghezzi, M. Taiana, G. Comi, S. Corti, M. Nizzardo
Evaluation of Morpholino oligomers therapeutic efficacy in C9orf72 ALS iPSC-derived lines
2020 M. Bersani, M. Taiana, F. Biella, M. Nizzardo, S. Ghezzi, N. Bresolin, G.P. Comi, S. Corti
Changes in pathological phenotype of C9orf72 ALS iPSC-derived lines after treatment with Morpholino oligomers
2020 M. Bersani, M. Taiana, F. Biella, M. Nizzardo, S. Ghezzi, S. Corti
Neural stem cell transplantation for neurodegenerative diseases
2020 R. De Gioia, F. Biella, G. Citterio, F. Rizzo, E. Abati, M. Nizzardo, N. Bresolin, G.P. Comi, S. Corti
Cell Penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
2020 E. Pagliari, M. Bersani, M. Rizzuti, A. Bordoni, D. Saccomanno, H.M. Moulton, N. Bresolin, G.P. Comi, S. Corti, M. Nizzardo
Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)
2020 M.G.L. Perego, N. Galli, M. Nizzardo, A. Govoni, M. Taiana, N. Bresolin, G.P. Comi, S. Corti
Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow
2020 V. Mishra, D.B. Re, V. Le Verche, M.J. Alvarez, A. Vasciaveo, A. Jacquier, P. Doulias, T.M. Greco, M. Nizzardo, D. Papadimitriou, T. Nagata, P. Rinchetti, E.J. Perez-Torres, K.A. Politi, B. Ikiz, K. Clare, M.E. Than, S. Corti, H. Ischiropoulos, F. Lotti, A. Califano, S. Przedborski
Synaptotagmin 13 is neuroprotective across motor neuron diseases
2020 M. Nizzardo, M. Taiana, F. Rizzo, J. Aguila Benitez, J. Nijssen, I. Allodi, V. Melzi, N. Bresolin, G.P. Comi, E. Hedlund, S. Corti
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis
2020 A. Loffreda, M. Nizzardo, A. Arosio, M. Ruepp, R.A. Calogero, S. Volinia, M. Galasso, C. Bendotti, C. Ferrarese, C. Lunetta, M. Rizzuti, A. Ronchi, O. Mühlemann, L. Tremolizzo, S. Corti, S.M.L. Barabino
Animal Models of CMT2A: State-of-art and Therapeutic Implications
2020 R. De Gioia, G. Citterio, E. Abati, M. Nizzardo, N. Bresolin, G.P. Comi, S. Corti, F. Rizzo
Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights
2020 M. Saladini, M. Nizzardo, A. Govoni, M. Taiana, N. Bresolin, G.P. Comi, S. Corti
IGHMBP2 related pathological pathways in Spinal Muscular Atrophy with Respiratory Distress type 1 (SMARD1) in vitro models
2019 N. Galli, M. Taiana, E. Pagliari, S. Ghezzi, G. Comi, S. Corti, M. Nizzardo